Literature DB >> 21227990

Cellulosimicrobium funkei: first report of infection in a nonimmunocompromised patient and useful phenotypic tests for differentiation from Cellulosimicrobium cellulans and Cellulosimicrobium terreum.

Hawabibee Petkar1, Anthony Li, Nicholas Bunce, Kim Duffy, Henry Malnick, Jayesh J Shah.   

Abstract

Cellulosimicrobium funkei is a rare, opportunistic pathogen. We describe a case of bacteremia and possibly prosthetic valve endocarditis by this organism in a nonimmunocompromised patient. Useful phenotypic tests for differentiating C. funkei from Cellulosimicrobium cellulans and Cellulosimicrobium terreum include motility, raffinose fermentation, glycogen, D-xylose, and methyl-α-D-glucopyranoside assimilation, and growth at 35°C.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21227990      PMCID： PMC3067735          DOI： 10.1128/JCM.01103-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Reclassification of Cellulomonas cellulans (Stackebrandt and Keddie 1986) as Cellulosimicrobium cellulans gen. nov., comb. nov.

Authors:  P Schumann; N Weiss; E Stackebrandt
Journal:  Int J Syst Evol Microbiol       Date:  2001-05       Impact factor: 2.747

2.  Catheter-related bacteremia caused by Oerskovia turbata.

Authors:  C R LeProwse; M M McNeil; J M McCarty
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

3.  Clearance of Cellulosimicrobium cellulans bacteremia in a child without central venous catheter removal.

Authors:  Marie-Claire Rowlinson; David A Bruckner; Claudia Hinnebusch; Karin Nielsen; Jaime G Deville
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  A prospective randomized comparison of Medtronic Mosaic and Carpentier-Edwards-SAV in the aortic position: an interim report.

Authors:  Anil John; Zamir Khan; James Kuo; Simon M Allen; Adrian J Marchbank; Malcolm J R Dalrymple-Hay; C Terence Lewis; Gina Twine; Maxine Edwards; Jonathan Unsworth-White
Journal:  J Heart Valve Dis       Date:  2006-05

5.  Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?

Authors:  F Dagenais; P Cartier; P Voisine; D Desaulniers; J Perron; R Baillot; G Raymond; J Métras; D Doyle; P Mathieu
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

6.  Bacterial endocarditis caused by Oerskovia turbata.

Authors:  L B Reller; G L Maddoux; M R Eckman; G Pappas
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

7.  Characterization of clinical isolates previously identified as Oerskovia turbata: proposal of Cellulosimicrobium funkei sp. nov. and emended description of the genus Cellulosimicrobium.

Authors:  June M Brown; Arnold G Steigerwalt; Roger E Morey; Maryam I Daneshvar; Leslie-Joy Romero; Michael M McNeil
Journal:  Int J Syst Evol Microbiol       Date:  2006-04       Impact factor: 2.747

8.  Molecular epidemiologic evaluation of endocarditis due to Oerskovia turbata and CDC group A-3 associated with contaminated homograft valves.

Authors:  Michael M McNeil; June M Brown; Michelle E Carvalho; Dannie G Hollis; Roger E Morey; L Barth Reller
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

9.  Cellulosimicrobium terreum sp. nov., isolated from soil.

Authors:  Jung-Hoon Yoon; So-Jung Kang; Peter Schumann; Tae-Kwang Oh
Journal:  Int J Syst Evol Microbiol       Date:  2007-11       Impact factor: 2.747
  9 in total
  10 in total

1.  Genome sequence analysis and bioactivity profiling of marine-derived actinobacteria, Brevibacterium luteolum, and Cellulosimicrobium funkei.

Authors:  Faouzia Tanveer; Muhammad Shehroz; Muhammad Ali; Yunying Xie; Rashda Abbasi; Zabta Khan Shinwari; Azra Yasmin
Journal:  Arch Microbiol       Date:  2021-03-07       Impact factor: 2.552

Review 2.  The genus corynebacterium and other medically relevant coryneform-like bacteria.

Authors:  Kathryn Bernard
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

3.  Cellulosimicrobium cellulans aortic prosthetic valve endocarditis.

Authors:  Jacopo Monticelli; Riccardo Gerloni; Claudio Farina; Anna Knezevich; Franca Dore; Roberto Luzzati
Journal:  Access Microbiol       Date:  2019-10-21

4.  Cellulosimicrobium fucosivorans sp. nov., isolated from San Elijo Lagoon, contains a fucose metabolic pathway linked to carotenoid production.

Authors:  Fabiola A Aviles; John A Kyndt
Journal:  Arch Microbiol       Date:  2021-06-20       Impact factor: 2.552

5.  A novel strain of Cellulosimicrobium funkei can biologically detoxify aflatoxin B1 in ducklings.

Authors:  Lv-Hui Sun; Ni-Ya Zhang; Ran-Ran Sun; Xin Gao; Changqin Gu; Christopher Steven Krumm; De-Sheng Qi
Journal:  Microb Biotechnol       Date:  2015-01-23       Impact factor: 5.813

6.  (Meta)genomic insights into the pathogenome of Cellulosimicrobium cellulans.

Authors:  Anukriti Sharma; Jack A Gilbert; Rup Lal
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

7.  Draft Genome Sequence of Multidrug-Resistant Cellulosimicrobium sp. Strain KWT-B, Isolated from Feces of Hirundo rustica.

Authors:  Takehiko Kenzaka; Yuina Ishimoto; Katsuji Tani
Journal:  Genome Announc       Date:  2017-07-13

8.  Draft Genome Sequence of Cellulosimicrobium sp. Strain MM, Isolated from Arsenic-Rich Microbial Mats of a Himalayan Hot Spring.

Authors:  Anukriti Sharma; Princy Hira; Mallikarjun Shakarad; Rup Lal
Journal:  Genome Announc       Date:  2014-10-09

9.  Study of the Aminoglycoside Subsistence Phenotype of Bacteria Residing in the Gut of Humans and Zoo Animals.

Authors:  Teresita de J Bello González; Tina Zuidema; Gerrit Bor; Hauke Smidt; Mark W J van Passel
Journal:  Front Microbiol       Date:  2016-01-11       Impact factor: 5.640

10.  Bacteremia caused by cellulosimicrobium in a bone marrow transplant patient: A case report and literature review.

Authors:  Jose Armando Gonzales Zamora; Nicholas Camps
Journal:  IDCases       Date:  2018-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.